Patients with higher levels of NT-proBNP had an increased risk for composite outcome (all-cause mortality, cardiovascular mortality, recurrent MI, HF, stroke) both within 30 days and >30 days after incident MI [6]. This evidence concerns the gene NPPB and Stroke.